Balance Sheet

Accounts Payables Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Growth Metrics

Trulieve Cannabis (TCNNF) Accumulated Expenses (2021 - 2022)

Trulieve Cannabis has reported Accumulated Expenses over the past 2 years, most recently at $19.5 million for Q4 2022.

For Q4 2022, Accumulated Expenses fell 20.95% year-over-year to $19.5 million; the TTM value through Dec 2022 reached $19.5 million, down 20.95%, while the annual FY2022 figure was $19.5 million, 20.95% down from the prior year.
Accumulated Expenses for Q4 2022 was $19.5 million at Trulieve Cannabis, down from $27.2 million in the prior quarter.
Over five years, Accumulated Expenses peaked at $27.2 million in Q1 2022 and troughed at $19.5 million in Q4 2022.